Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+5.25%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$57.2B
AUM Growth
+$551M
(+0.97%)
Cap. Flow
-$296M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,007
New
143
Increased
295
Reduced
385
Closed
137
Top Buys
| 1 |
ConocoPhillips
COP
|
$230M |
| 2 |
Bristol-Myers Squibb
BMY
|
$185M |
| 3 |
WESCO International
WCC
|
$171M |
| 4 |
Gilead Sciences
GILD
|
$158M |
| 5 |
Delta Air Lines
DAL
|
$148M |
Top Sells
| 1 |
MRO
Marathon Oil Corporation
MRO
|
$221M |
| 2 |
3M
MMM
|
$154M |
| 3 |
Marsh & McLennan
MMC
|
$115M |
| 4 |
Johnson & Johnson
JNJ
|
$99M |
| 5 |
Novo Nordisk
NVO
|
$94.6M |
Sector Composition
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
BJs Wholesale Club
BJ
$12.8B
| $4.47M | 0.01% |
+50,000
| New | +$4.47M |
|
|
CDMO
727
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $4.41M | 0.01% |
+357,041
| New | +$4.41M |
|
728
Revvity
RVTY
$10.1B
| $4.32M | 0.01% |
38,688
-27,600
| -42% | -$3.08M |
|
729
CubeSmart
CUBE
$9.52B
| $4.29M | 0.01% |
+100,000
| New | +$4.29M |
|
730
Karyopharm Therapeutics
KPTI
$57.2M
| $4.27M | 0.01% |
421,323
+133,334
| +46% | +$1.35M |
|
731
NET Power
NPWR
$171M
| $4.24M | 0.01% |
400,000
-200,000
| -33% | -$2.12M |
|
732
Icon
ICLR
$13.6B
| $4.13M | 0.01% |
+19,677
| New | +$4.13M |
|
733
TPG
TPG
$8.64B
| $4.08M | 0.01% |
+65,000
| New | +$4.08M |
|
734
Pebblebrook Hotel Trust
PEB
$1.4B
| $4.07M | 0.01% |
300,000
-50,000
| -14% | -$678K |
|
735
Oric Pharmaceuticals
ORIC
$1.06B
| $4.04M | 0.01% |
500,000
-75,000
| -13% | -$605K |
|
736
Vale
VALE
$44.4B
| $3.99M | 0.01% |
+450,000
| New | +$3.99M |
|
737
Vericel Corp
VCEL
$1.72B
| $3.94M | 0.01% |
+71,800
| New | +$3.94M |
|
738
Dianthus Therapeutics
DNTH
$853M
| $3.92M | 0.01% |
+180,000
| New | +$3.92M |
|
739
Kimbell Royalty Partners
KRP
$1.25B
| $3.9M | 0.01% |
240,000
+20,000
| +9% | +$325K |
|
740
Regenxbio
RGNX
$490M
| $3.87M | 0.01% |
+500,000
| New | +$3.87M |
|
741
Akamai
AKAM
$11.3B
| $3.86M | 0.01% |
40,400
-77,400
| -66% | -$7.4M |
|
742
Twilio
TWLO
$16.7B
| $3.78M | 0.01% |
+35,000
| New | +$3.78M |
|
743
Hormel Foods
HRL
$14.1B
| $3.75M | 0.01% |
119,546
-154,400
| -56% | -$4.84M |
|
744
Globe Life
GL
$11.3B
| $3.72M | 0.01% |
33,400
-21,300
| -39% | -$2.38M |
|
745
Sutro Biopharma
STRO
$89.9M
| $3.68M | 0.01% |
2,000,000
-250,132
| -11% | -$460K |
|
|
ATYR
746
aTyr Pharma
ATYR
$550M
| $3.62M | 0.01% |
1,000,000
| – | – |
|
747
Essential Properties Realty Trust
EPRT
$6.1B
| $3.6M | 0.01% |
115,000
-35,000
| -23% | -$1.09M |
|
748
American Homes 4 Rent
AMH
$12.9B
| $3.59M | 0.01% |
+95,928
| New | +$3.59M |
|
749
Glaukos
GKOS
$5.39B
| $3.51M | 0.01% |
23,398
-150,000
| -87% | -$22.5M |
|
750
Avient
AVNT
$3.45B
| $3.47M | 0.01% |
+85,000
| New | +$3.47M |
|